5 Best Safest Stocks To Watch Right Now

Source: StockMonkeys.com

Not all dividend stocks are created equal. Some offer monstrous 10% yields or more, but their share prices dwindle with each passing year.

With that in mind, I have identified two dividend stocks that offer above-average yields and have characteristics that suggest they should be safer than most massive yielders.

A niche New York bank
New York Community Bancorp (NYSE: NYCB  ) �is�one of the highest-yielding banks, and arguably one of the safest.

The bank focuses on lending to multifamily investors in the New York City area, where rents are seemingly always on the rise and demand for housing is permanently strong. Due to the underlying characteristics of the real estate market, the bank's credit metrics are often near the top of the industry, even during the depths of the financial crisis.

The stock is no slouch, though. Today's buyers will pay about 16 times last year's earnings. But because the bank pays out almost all of its income each year, the stock yields a respectable 6.7% dividend.

Top 5 Tech Stocks To Invest In 2015: Monsanto Co (MON)

Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a provider of agricultural products for farmers. The Company's seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity. In April 2010, the Company completed the acquisition of a corn and soybean processing plant located in Paine, Chile from Anasac, a company that provides seed processing services. In October 2009, the Company completed the acquisition of Seminium, S.A. (Seminium), a corn seed company. In February 2011, the Company acquired Divergence, Inc. In September 2011, the Company acquired Beeologics. In June 2012, the Company purchased a planting technology developer, Precision Planting, Inc. In January 2013, it purchased select assets of Agradis, Inc. In June 2013, Monsanto Company acquired GrassRoots Biotechnology Inc. In November 2013, the Company announced that it has completed the acquisition of The Climate Corporation.

Seeds and Genomics Segment

Through the Company's Seeds and Genomics segment, it produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds. It also provides other seed companies with genetic material and biotechnology traits for their seed brands. It has a global distribution and sales and marketing organization for its seeds and traits. It sells products under Monsanto brands and license technology and genetic material to others for sale under their own brands. Through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, it markets DEKALB, Asgrow and Deltapine branded germplasm to farmers globally. In the United States, it markets regional seed brands under it! s American Seeds, LLC and Channel Bio, LLC businesses to farmers directly, as well as through dealers, agricultural cooperatives and agents. It markets and sells trait technologies with branded germplasm, pursuant to license agreements with its farmer customers. In Brazil and Paraguay, its has implemented a point-of-delivery, grain-based payment system. It contracts with grain handlers to collect applicable trait fees when farmers deliver their grain. In addition to selling its products under its own brands, the Company licenses a range of germplasm and trait technologies to large and small seed companies in the United States and certain international markets. Those seed companies in turn market its trait technologies in their branded germplasm; they may also market its germplasm under its own brand name. Its vegetable seeds are marketed in more than 100 countries through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers and agents, as well as directly to farmers.

The Company�� row crop seeds brands include DEKALB, Channel Bio, Asgrow and Deltapine. Its DEKALB and Channel Bio are corn hybrids and foundation seed. Its Asgrow are soybean varieties and foundation seed. Its Deltapine are cotton varieties, hybrids and foundation seed. Canola is its row crop variety and hybrid. Its vegetable seed brands are Seminis and De Ruiter. These are open field and protected-culture seed for tomato, pepper, eggplant, melon, cucumber, pumpkin, squash, beans, broccoli, onions, and lettuce, among others. Its Biotechnology traits include SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, VT Double PRO, Roundup Ready and Roundup Ready 2 Yield and Genuity. Its SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO and VT Double PRO have applications for corn, and Bollgard and Bollgard II have application for cotton. It enables crops to protect themselves from borers and rootworm in corn and leaf- and boll-feeding worms in cotton, reducing the need for application! s of inse! cticides. Its Roundup Ready and Roundup Ready 2 Yield have application for soybeans. The Company�� Genuity is a global umbrella trait brand. It enables crops, such as corn, soybeans, cotton, and canola to be tolerant of Roundup and other glyphosate-based herbicides. Monsanto also offers farmers stacked-trait products, which are single-seed products in which two or more traits are combined.

Agricultural Productivity Segment

Through the Company's Agricultural Productivity segment, it manufactures Roundup brand herbicides and other herbicides and provide lawn-and-garden herbicide products for the residential market. Its products include Glyphosate-based herbicides, Selective herbicides and Lawn-and-garden herbicides. Its Glyphosate-based herbicides have applications in nonselective agricultural, industrial, ornamental and turf applications for weed control. Its Selective herbicides control preemergent annual grass and small seeded broadleaf weeds in corn and other crops. Its residential lawn-and-garden has applications for weed control. It uses the same distribution and sales and marketing organization for its crop protection products as for its seeds and traits. It also has separate distribution and sales and marketing organizations for its crop protection products. It sells crop protection products through distributors, independent retailers and dealers and agricultural cooperatives. In some cases outside the United States, it sells such products directly to farmers. It also sells certain of the chemical intermediates of its crop protection products to other agricultural chemical producers, who then market their own branded products to farmers. The Company markets its lawn-and-garden herbicide products through The Scotts Miracle-Gro Company.

Advisors' Opinion:

• [By Rich Duprey]

  Last week, I noted how an Australian farmer was suing a neighboring farmer for contaminating his organic fields with Monsanto's (NYSE: MON  ) GM seed, potentially changing the dynamic in how fields can be protected. Rather than go after the seed giant itself, which has never lost a case, suing the individual farmers who've caused the cross-contamination may cause Monsanto to become a pariah among seed buyers.

5 Best Safest Stocks To Watch Right Now: Protalix Biotherapeutics Inc (PLX)

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX-105.

Taliglucerase Alfa

Taliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Its oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme. Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell�� cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines. Additionally, rats fed with lyophilized carrot cells expressing GCD have accumulated the active enzyme in the target organs; the spleen and liver. As of December 31, 2010, the Company had completed Phase III Clinical Trial.

PRX-102

The Company is developing PRX-102, its plant cell expressed modified version of the recombinant ! alpha-GAL-A protein, a therapeutic enzyme for the treatment of Fabry disease. Fabry disease is a rare, hereditary, genetic lysosomal storage disorder in humans caused by an X-lined deficiency of the alpha-GAL-A enzyme. The Company is in the animal evaluation testing phase of the development of PRX-102, which tests are based on a mouse model for Fabry disease.

Acetylcholinesterase

Protalix Ltd. is a wholly owned subsidiary of the Company is licensed the rights to certain technology under a research and license agreement with Yissum Research and Development Company (Yissum) and the Boyce Thompson Institute, Inc. Pursuant to the agreement, the Company is developing PRX-105, a plant cell-based acetylcholinesterase (AChE) and its molecular variants for the use in several therapeutic and prophylactic indications, as well as in a biodefense program and an organophosphate-based pesticide treatment program.

As of December 31, 2010, its in-vitro experiments of PRX-105 have shown that the acetylcholinesterase enzyme in its ProCellEx protein expression system demonstrates biological activity on biochemical and cellular levels. In addition, early animal studies demonstrated that the acetylcholinesterase expressed in its ProCellEx protein expression system was able to treat animals exposed to the nerve gas agent analogues, both when injected with its acetylcholinesterase product candidate immediately before exposure or when injected after exposure. In March 2010, it initiated a preliminary phase I clinical trial of PRX-105, which the Company completed in June 2010.

pr-antiTNF

pr-antiTNF is a candidate for the treatment of certain autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis. The Company has designed the antiTNF as pr-antiTNF. pr-antiTNF is a plant cell-expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR), f! used to t! he Fc component of a human antibody domain. pr-antiTNF has an identical amino acid sequence to Enbrel and its in-vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel. Specifically, pr-antiTNF binds TNF thereby inhibiting it from binding to cellular surface TNF receptors and protects L929 cells from TNF-induced apoptosis in a dose-dependent manner.

The Company competes with Genzyme, Actelion, Crucell N.V., Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, Symbiosys, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.

Advisors' Opinion:

• [By Keith Speights]

  Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX  ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a "broad array of strategic alternatives."

• [By Maxx Chatsko]

  Industrial biotech isn't the only industry headed to Brazil. Protalix (NYSEMKT: PLX  ) entered into a technology transfer agreement with Brazil's Ministry of Health last week that will pay the company $280 million. The deal is big news for Protalix's first product, Elelyso/Uplyso, which was developed with partner Pfizer (NYSE: PFE  ) . The treatment is approved as an enzyme replacement therapy, or ERT, for adults with type 1 Gaucher disease, and it marks a huge step forward for the future of biomanufacturing. In the following video, Fool contributor Maxx Chatsko explains what this means for the product's commercialization and the adoption of Protalix's novel plant cell-based expression system for therapeutic proteins.

5 Best Safest Stocks To Watch Right Now: Dolby Laboratories Inc (DLB)

Dolby Laboratories, Inc., incorporated in 1967, develops and delivers products and technologies that are used in the entertainment industry. Its audio technologies are used throughout the global entertainment industry. It is developing and marketing video technologies to improve the quality of video presentation. Its offerings include video products aimed at the cinema market, such as its digital cinema server, its Dolby three-dimensional (3D) Digital Cinema products, and its Dolby PRM-4200 Professional Reference Monitor. It offers products and services to content creators, such as studios, broadcasters, and downloadable content service providers to encode content using Dolby�� technologies. As of September 24, 2010, the Company sold its products and provide services in over 85 countries. In addition, it has licensed its technologies to CE manufacturers and to software vendors in 40 countries, which in turn distribute their products incorporating its technologies throughout the world.

The Company designs and manufactures video and audio products for the film production, cinema, and television broadcast industries. Distributed in over 60 countries, these products are used in content creation, distribution and playback to improve image and sound quality, provide surround sound, and increase the efficiency of sound storage and distribution. Its product sales are derived from sales of its digital 3D products, which provide 3D capabilities, as well as sales of digital cinema servers that load, store, decrypt, and decode encrypted digital film files for presentation on digital projectors in theaters. Revenue is also derived from sales of its traditional cinema processors, which movie theaters use to process film soundtracks, and from sales of broadcast products used to encode and distribute content to viewers. It also offers related digital cinema processors and media adapters to decode digital cinema soundtracks, and digital cinema accessories that allow exhibitors to integrate its digital ! cinema servers with their existing automation systems.

The Company offers a variety of services to support film production, television broadcast and music production. The Company enters into service agreements with motion picture studios or filmmakers to provide them with production services related to the preparation of a Dolby soundtrack, such as equipment calibration, mixing room alignment and equalization. Dolby provides other services, such as print quality control, professional film mastering services to prepare movies for digital release, and theatre system calibration for important screenings, such as premieres, film festivals, and press screenings. Its engineers also provide training, system design consultation and onsite technical expertise to cinema operators throughout the world to help them configure their screening rooms and equipment to ensure that movies are replayed with consistent high quality.

The Company�� technologies include dolby digital, dolby digital plus, dolby digital surround EX, dolby digital EX, advanced audio coding (AAC), HE AAC, dolby pulse, dolby trueHD, dolby E, dolby digital live, dolby pro logic II, dolby pro logic II(x), dolby pro logic IIz, dolby virtual speaker, dolby headphone, dolby mobile, dolby axon, PC entertainment experience (PCEE), dolby digital stereo creator, dolby digital 5.1 creator, dolby volume, dolby contrast, dolby vision and analog signal processing technologies. Its products include traditional cinema processors, digital cinema products, digital 3D products, digital media adapters, broadcast products and professional reference monitor.

Traditional cinema processors are used to read, decode and play back a film�� soundtrack and calibrate the sound system in a movie theater. Digital cinema products are used for digital cinema encoding, distribution and playback. Our digital cinema server is used to load, store, decrypt, decode and re-encrypt digital film files for presentation on a digital cinema project! or. We al! so provide products that encrypt, encode and package digital films, and digital cinema processors to decode digital cinema soundtracks. Digital 3D products deliver a 3D image with an existing digital cinema server and white screen, providing exhibitors a flexible 3D solution. Its Dolby 3D glasses feature high-quality multicoated lenses with a special curvature that delivers 3D images.

Digital media adapters are used to adapt existing analog cinema audio systems to the latest digital audio technologies. Broadcast products are used to encode, transmit and decode multiple channels of high-quality audio for Digital Television (DTV) and high-definition television (HDTV) program production and broadcast distribution and to measure the subjective loudness of audio content within broadcast programming. Professional reference monitor is a video monitor used during the production and post-production of cinematic and video content in situations, where grade one reference performance is required.

The Company competes with Audyssey Laboratories, DTS, Fraunhofer Institute for Integrated Circuits, Microsoft, Philips, RealNetworks, Sonic Solutions, Sony, SRS Labs, Thomson, Barco, Doremi, GDC, IMAX, MasterImage 3D, NEC, Panavision, QSC Audio Products, Qube Cinema, REAL D, Technicolor, Texas Instruments, USL, XpanD and DTS.

Advisors' Opinion:

• [By Steve Symington]

  Given the last 2.5 years, it seems an understatement to say Dolby (NYSE: DLB  ) shareholders have had it tough.

  Following the stock's relentless climb through the end of 2011, shares of the audio specialist have underperformed the S&P 500 by almost 75% as demand for its products waned in its core PC, DVD, and Blu-ray device markets:

• [By Tim Melvin]

  Price�� new buys in the quarter were Oenok (OKE), Dolby Labs (DLB) and T-Mobile (TMUS). I don�� find any of those particularly exciting at current levels, but I�� willing to acknowledge that Michael Price is a lot smarter than I am and probably sees value I am missing in these stocks. What I find much more interesting was that Price was doing a lot more selling than buying in the third quarter.

• [By Sue Chang]

  Dolby Laboratories (DLB) : ��he Hobbit: The Desolation of Smaug��is presented in Dolby Surround 7.1. The stock is up 28% so far in 2013.

5 Best Safest Stocks To Watch Right Now: Sensient Technologies Corp (SXT)

Sensient Technologies Corporation, incorporated on December 07, 1882, is a global manufacturer and marketer of colors, flavors and fragrances. Sensient uses advanced technologies at facilities around the world to develop specialty food and beverage systems, cosmetic and pharmaceutical systems, inkjet and specialty inks and colors, and other specialty and chemicals. The Company�� customers include international manufacturers representing some of the Known brands. The Company operates in two segments: Flavors & Fragrances Group and the Color Group. The Asia Pacific and the China Groups are included in the Corporate & Other category, along with the Company�� corporate expenses. The Company's principal products include: flavors, flavor enhancers and bionutrients; fragrances and aroma chemicals; dehydrated vegetables and other food ingredients; natural and synthetic food and beverage colors; cosmetic and pharmaceutical colors and additives; and technical colors, inkjet colors and inks, and specialty dyes and pigments.

Flavors & Fragrances Group

The Company is a developer, manufacturer and supplier of flavor and fragrance systems for the food, beverage, pharmaceutical, personal care and household-products industries. The Company�� flavor formulations are used in consumer products. Under the unified brand names of Sensient Flavors, Sensient Dehydrated Flavors and Sensient Fragrances, the Company is a supplier to multinational companies. The Flavors & Fragrances Group produces flavor and fragrance products, which impart a taste, texture, aroma and/or other characteristics to a range of consumer and other products. It includes the Company�� dehydrated flavors business, which produces ingredients for food processors. The products are systems products, including flavor-delivery systems, and compounded and blended products. In addition, the Company is engaged in selected ingredient products, such as essential oils, natural and synthetic flavors, and aroma chemicals. The Company ! serves food and non-food industries. In food industries, markets include savory, beverage, dairy, confectionery and bakery flavors. In non-food industries, the Company supplies fragrance products to the personal and home-care markets and supplies flavor products to the pharmaceuticals market.

Operating through the Company�� Sensient Dehydrated Flavors business, the Company is produces dehydrated onion and garlic products in the United States. The Company is also producers and distributors of chili powder, paprika, chili pepper and dehydrated vegetables, such as parsley, celery and spinach. Domestically, the Company sells dehydrated products to food manufacturers for use as ingredients and also for repackaging under private labels for sale to the retail market and to the food service industry. In addition, Sensient Dehydrated Flavors is dehydrators of specialty vegetables in Europe. The Flavors & Fragrances Group operates through the Company's subsidiaries Sensient Flavors LLC and Sensient Dehydrated Flavors LLC. The Company�� principal manufacturing plants are located in California, Illinois, Indiana, Michigan, Wisconsin, Belgium, Canada, the People�� Republic of China, France, Germany, Italy, Mexico, the Netherlands, Spain and the United Kingdom.

Color Group

The Company is a developer, manufacturer and supplier of colors for businesses globally. The Company provides natural and synthetic color systems for use in foods, beverages and pharmaceuticals; colors and other ingredients for cosmetics and pharmaceuticals, and technical colors for industrial applications and digital imaging. The Company sells its synthetic and natural colors to domestic and international producers of beverages, bakery products, processed foods, confections, pet foods, cosmetics and pharmaceuticals. The Company also makes inkjet inks and other dyes and pigments used in a variety of non-food applications.

The Color Group operates through the Company's subsidiary Sensient Col! ors LLC. ! Its principal manufacturing plants are located in California, Missouri, New Jersey, Brazil, Canada, Mexico, France, Germany, Hungary, Italy, Switzerland and the United Kingdom. The Color Group operates under trade names of Sensient Food Colors (food and beverage colors); Sensient Pharmaceutical Coating Systems (pharmaceutical colors and coatings); Sensient Cosmetic Technologies (cosmetic colors and ingredients and systems). and Sensient Industrial Colors (including paper colors; industrial colors for plastics, leather, wood stains, antifreeze and other uses; inkjet colors and inks; specialty inks, and display imaging).

Asia Pacific and China Groups

The Asia Pacific Group and the China Group focus on marketing the Company�� diverse product line in the Pacific Rim under the Sensient name. Through these operations, the Company offers a range of products from its Flavors & Fragrances Group and Color Group, as well as products developed by regional technical teams to appeal to local preferences. Sales, marketing and technical functions are managed through the Asia Pacific Group's headquarters in Australia. Manufacturing operations are located in Australia, Japan, New Zealand and the Philippines. The Asia Pacific Group maintains offices for research and development, as well as sales, in India, Indonesia, Korea, Singapore and Thailand.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Sensient Technologies (NYSE: SXT  ) , whose recent revenue and earnings are plotted below.